Lars Green

Lars Green currently works at LEO Pharma A, as Director, Leo Pharma, Inc., as Director from 2021, Novo Nordisk Fonden, as Director, Novo Holdings A, as Director, Pharmacosmos A, as Director, The Danish Business Authority, as Director, LEO Holding A, as Director from 2020, H.
Lundbeck A, as Independent Director from 2025, Novo Nordisk, Inc., as Senior Vice President-Finance & Operations from 2014, and LEO Fondet, as Trustee.
Mr. Green also formerly worked at Novo Nordisk A, as Vice President-Corporate Finance in 2011, Novo Nordisk A, as Executive VP, Head-Business Services & Compliance from 2017 to 2019, Novozymes A, as Chief Financial Officer & Executive Vice President from 2019 to 2023, and Scandinavian Investment Group A, as Member-Supervisory Board in 2011.
Mr. Green received his graduate degree in 1992 from the University of Aarhus.